Litcius/Paper detail

Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases

Thomas F. Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, Xiaoyun Wu, Tricia L. May‐Dracka, Jan Antoinette C. Romero, Frank Wu, April Chen, Adam B. Shapiro, Nicole Carter, Sarah M. McLeod, R.A. Giacobbe, Jeroen C. Verheijen, Sushmita D. Lahiri, M. Sacco, Yu Chen, John P. O’Donnell, Alita A. Miller, John P. Mueller, Rubén Tommasi

2020Journal of Medicinal Chemistry61 citationsDOIOpen Access PDF

Abstract

infections.

Topics & Concepts

ChemistryProdrugAntibioticsPharmacologyOral administrationBioavailabilityEnzymeSerineBiochemistryMedicineAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPneumocystis jirovecii pneumonia detection and treatment
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases | Litcius